Total Payments
$122,008
2024 Payments
$64,749
Companies
13
Transactions
151
Medicare Patients
2,322
Medicare Billing
$334,522
Payment Breakdown by Category
Other$59,878 (49.1%)
Consulting$29,992 (24.6%)
Research$19,000 (15.6%)
Travel$10,144 (8.3%)
Food & Beverage$2,888 (2.4%)
Education$106.11 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $59,028 | 17 | 48.4% |
| Consulting Fee | $29,992 | 6 | 24.6% |
| Unspecified | $19,000 | 4 | 15.6% |
| Travel and Lodging | $10,144 | 46 | 8.3% |
| Food and Beverage | $2,888 | 74 | 2.4% |
| Honoraria | $850.00 | 1 | 0.7% |
| Education | $106.11 | 3 | 0.1% |
Payments by Type
General
$103,008
147 transactions
Research
$19,000
4 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $54,301 | 40 | $0 (2024) |
| Lilly USA, LLC | $30,805 | 38 | $0 (2024) |
| ACADIA Pharmaceuticals Inc | $19,321 | 17 | $0 (2024) |
| Corium, LLC | $12,424 | 10 | $0 (2023) |
| Eisai Inc. | $1,196 | 17 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,136 | 6 | $0 (2019) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $1,094 | 8 | $0 (2024) |
| Lundbeck LLC | $927.35 | 5 | $0 (2024) |
| Biogen, Inc. | $601.39 | 3 | $0 (2021) |
| Inspire Medical Systems, Inc. | $95.77 | 4 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $64,749 | 80 | Otsuka America Pharmaceutical, Inc. ($32,762) |
| 2023 | $35,273 | 42 | Otsuka America Pharmaceutical, Inc. ($21,539) |
| 2022 | $16.28 | 1 | ABBVIE INC. ($16.28) |
| 2021 | $560.01 | 2 | Biogen, Inc. ($560.01) |
| 2019 | $19,152 | 7 | ACADIA Pharmaceuticals Inc ($19,000) |
| 2018 | $38.00 | 1 | Genentech, Inc. ($38.00) |
| 2017 | $2,220 | 18 | Novartis Pharmaceuticals Corporation ($1,110) |
All Payment Transactions
151 individual payment records from CMS Open Payments — Page 6 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2019 | Eisai Inc. | — | Food and Beverage | Cash or cash equivalent | $50.60 | General |
| 09/04/2019 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | — | Cash or cash equivalent | $6,000.00 | Research |
| Study: ACA 16-cAC-0001 • Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 09/04/2019 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | — | Cash or cash equivalent | $6,000.00 | Research |
| Study: ACA 16-cAC-0001 • Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 07/17/2019 | Novartis Pharmaceuticals Corporation | API015 (Drug) | Food and Beverage | In-kind items and services | $25.45 | General |
| 07/15/2019 | Eisai Inc. | — | Food and Beverage | Cash or cash equivalent | $75.79 | General |
| 05/09/2019 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | — | Cash or cash equivalent | $3,500.00 | Research |
| Study: ACA 16-cAC-0001 • Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 05/09/2019 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | — | Cash or cash equivalent | $3,500.00 | Research |
| Study: ACA 16-cAC-0001 • Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/08/2018 | Genentech, Inc. | Non-Covered Product (Drug) | Education | In-kind items and services | $38.00 | General |
| Category: None | ||||||
| 11/17/2017 | Novartis Pharmaceuticals Corporation | CNP520 (Drug) | Food and Beverage | In-kind items and services | $102.52 | General |
| 11/16/2017 | Novartis Pharmaceuticals Corporation | CNP520 (Drug) | Travel and Lodging | In-kind items and services | $465.92 | General |
| 11/16/2017 | Novartis Pharmaceuticals Corporation | CNP520 (Drug) | Food and Beverage | In-kind items and services | $114.99 | General |
| 11/16/2017 | Novartis Pharmaceuticals Corporation | CNP520 (Drug) | Travel and Lodging | Cash or cash equivalent | $60.63 | General |
| 11/15/2017 | Novartis Pharmaceuticals Corporation | — | Travel and Lodging | In-kind items and services | $366.00 | General |
| 09/12/2017 | Eisai Inc. | — | Travel and Lodging | Cash or cash equivalent | $353.40 | General |
| 09/12/2017 | Eisai Inc. | — | Travel and Lodging | Cash or cash equivalent | $224.25 | General |
| 09/12/2017 | Eisai Inc. | — | Travel and Lodging | Cash or cash equivalent | $133.50 | General |
| 09/12/2017 | Eisai Inc. | — | Food and Beverage | Cash or cash equivalent | $51.35 | General |
| 09/12/2017 | Eisai Inc. | — | Food and Beverage | Cash or cash equivalent | $51.35 | General |
| 09/12/2017 | Eisai Inc. | — | Food and Beverage | Cash or cash equivalent | $41.35 | General |
| 09/12/2017 | Eisai Inc. | — | Travel and Lodging | Cash or cash equivalent | $41.05 | General |
| 09/12/2017 | Eisai Inc. | — | Travel and Lodging | Cash or cash equivalent | $17.00 | General |
| 09/12/2017 | Eisai Inc. | — | Food and Beverage | Cash or cash equivalent | $13.04 | General |
| 09/12/2017 | Eisai Inc. | — | Food and Beverage | Cash or cash equivalent | $12.83 | General |
| 08/11/2017 | Biogen, Inc. | — | Education | In-kind items and services | $41.38 | General |
| 04/17/2017 | Lilly USA, LLC | AMYVID (Drug) | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: Neuroscience | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| ACA 16-cAC-0001 | ACADIA Pharmaceuticals Inc | $19,000 | 4 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 762 | 885 | $385,279 | $101,491 |
| 2022 | 6 | 501 | 573 | $258,681 | $76,352 |
| 2021 | 7 | 536 | 723 | $309,787 | $98,364 |
| 2020 | 6 | 523 | 602 | $224,046 | $58,316 |
Total Patients
2,322
Total Services
2,783
Medicare Billing
$334,522
Procedure Codes
28
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 253 | 367 | $147,901 | $42,838 | 29.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 215 | 215 | $122,765 | $31,524 | 25.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 163 | 163 | $75,143 | $17,037 | 22.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 81 | 89 | $26,789 | $7,155 | 26.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 27 | 28 | $5,712 | $1,511 | 26.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 23 | 23 | $6,969 | $1,425 | 20.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 240 | 306 | $116,280 | $39,858 | 34.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 71 | 71 | $44,940 | $10,897 | 24.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 68 | 68 | $38,828 | $10,672 | 27.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 33 | 38 | $15,314 | $4,744 | 31.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 34 | 34 | $15,674 | $3,928 | 25.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 17 | 17 | $9,390 | $2,132 | 22.7% |
| 99483 | Assessment of and care planning for impaired thought processing, typically 50 minutes | Office | 2022 | 15 | 15 | $11,898 | $1,902 | 16.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 12 | 12 | $3,381 | $1,160 | 34.3% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 11 | 12 | $2,976 | $1,058 | 35.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 227 | 324 | $123,120 | $43,659 | 35.5% |
| 99483 | Assessment of and care planning for patient with impaired thought processing, typically 50 minutes | Office | 2021 | 131 | 135 | $107,083 | $31,239 | 29.2% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 109 | 109 | $60,360 | $17,588 | 29.1% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 26 | 27 | $6,696 | $2,811 | 42.0% |
| 97530 | Therapeutic activities to improve function, with one-on-one contact between patient and provider, each 15 minutes | Office | 2021 | 18 | 52 | $5,148 | $1,416 | 27.5% |
| 97535 | Self-care or home management training, each 15 minutes | Office | 2021 | 12 | 40 | $3,960 | $858.22 | 21.7% |
| 97112 | Therapeutic procedure to re-educate brain-to-nerve-to-muscle function, each 15 minutes | Office | 2021 | 13 | 36 | $3,420 | $793.51 | 23.2% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 240 | 313 | $118,940 | $31,305 | 26.3% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 90 | 90 | $48,600 | $10,381 | 21.4% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 56 | 56 | $24,080 | $7,108 | 29.5% |
About Dr. Aaron Ritter, MD
Dr. Aaron Ritter, MD is a Psychiatry healthcare provider based in Las Vegas, Nevada. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/10/2010. The National Provider Identifier (NPI) number assigned to this provider is 1154633808.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Aaron Ritter, MD has received a total of $122,008 in payments from pharmaceutical and medical device companies, with $64,749 received in 2024. These payments were reported across 151 transactions from 13 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($59,028).
As a Medicare-enrolled provider, Ritter has provided services to 2,322 Medicare beneficiaries, totaling 2,783 services with total Medicare billing of $334,522. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Las Vegas, NV
- Active Since 07/10/2010
- Last Updated 07/07/2016
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1154633808
Products in Payments
- REXULTI (Drug) $56,322
- NUPLAZID (Drug) $19,321
- KISUNLA (Drug) $18,507
- Adlarity (Drug) $6,705
- Azstarys (Drug) $5,719
- CNP520 (Drug) $744.06
- ADUHELM (Biological) $560.01
- AMYVID (Drug) $322.02
- Leqembi (Drug) $130.01
- INSPIRE (Device) $95.77
- Non-Covered Product (Drug) $38.00
- API015 (Drug) $25.45
- DALVANCE (Drug) $16.28
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Las Vegas
Jelena Kunovac, M.d, M.D
Psychiatry — Payments: $1.4M
Psychiatry $1.4M
Dr. John Anooshian, Md, MD
Psychiatry — Payments: $861,533
Psychiatry $861,533
Sam Zand, D.o, D.O
Psychiatry — Payments: $350,533
Psychiatry $350,533
Dr. Mustafa Rawaf, Do, DO
Psychiatry — Payments: $150,352
Psychiatry $150,352
Dr. Faisal Suba, M.d, M.D
Psychiatry — Payments: $41,047
Psychiatry $41,047
Dr. Akindele Kolade, M.d, M.D
Psychiatry — Payments: $27,083
Psychiatry $27,083